MeiraGTx Holdings Plc (MGTX)
9.705
-0.04
(-0.46%)
USD |
NASDAQ |
Oct 29, 16:00
9.71
0.00 (0.00%)
After-Hours: 20:00
MeiraGTx Holdings Enterprise Value : 883.46M for Oct. 29, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 29, 2026 | 883.46M |
| October 28, 2026 | 887.70M |
| October 27, 2026 | 854.73M |
| October 26, 2026 | 834.01M |
| October 23, 2026 | 836.84M |
| October 22, 2026 | 889.58M |
| October 21, 2026 | 898.06M |
| October 20, 2026 | 908.42M |
| October 19, 2026 | 859.44M |
| October 16, 2026 | 843.43M |
| October 15, 2026 | 900.88M |
| October 14, 2026 | 855.67M |
| October 13, 2026 | 905.59M |
| October 12, 2026 | 947.04M |
| October 09, 2026 | 976.23M |
| October 08, 2026 | 958.34M |
| October 07, 2026 | 988.48M |
| October 06, 2026 | 967.76M |
| October 05, 2026 | 997.90M |
| October 02, 2026 | 985.65M |
| October 01, 2026 | 973.41M |
| September 30, 2026 | 1.005B |
| September 29, 2026 | 1.018B |
| September 28, 2026 | 1.016B |
| September 25, 2026 | 996.96M |
| Date | Value |
|---|---|
| September 24, 2026 | 1.010B |
| September 23, 2026 | 1.076B |
| September 22, 2026 | 1.133B |
| September 21, 2026 | 1.201B |
| September 18, 2026 | 1.217B |
| September 17, 2026 | 1.199B |
| September 16, 2026 | 1.171B |
| September 15, 2026 | 1.171B |
| September 14, 2026 | 1.183B |
| September 11, 2026 | 1.174B |
| September 10, 2026 | 1.180B |
| September 09, 2026 | 1.218B |
| September 08, 2026 | 1.244B |
| September 04, 2026 | 1.278B |
| September 03, 2026 | 1.285B |
| September 02, 2026 | 1.294B |
| September 01, 2026 | 1.306B |
| August 31, 2026 | 1.270B |
| August 28, 2026 | 1.271B |
| August 27, 2026 | 1.301B |
| August 26, 2026 | 1.341B |
| August 25, 2026 | 1.375B |
| August 24, 2026 | 1.366B |
| August 21, 2026 | 1.320B |
| August 20, 2026 | 1.339B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Xencor, Inc. | 1.885B |
| UroGen Pharma Ltd. | 1.723B |
| Ironwood Pharmaceuticals, Inc. | 915.91M |
| Viking Therapeutics, Inc. | 2.720B |
| IDEAYA Biosciences, Inc. | 2.370B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 160.67M |
| Revenue (Quarterly) | 321.43M |
| Total Expenses (Quarterly) | 160.71M |
| EPS Diluted (Quarterly) | 1.713 |
| Gross Profit Margin (Quarterly) | 96.89% |
| Profit Margin (Quarterly) | 49.99% |
| Earnings Yield | 7.27% |
| Operating Earnings Yield | 22.32% |
| Normalized Earnings Yield | 7.147 |